Back to Agenda
Session 9, Tracks C: New Era of Solutions, Practices and Demands for Pharmacovigilance Following the Impact of the COVID-19 Pandemic
Session Chair(s)
Gislaine Villarta Capeleti Dib, PharmD
Pharmacovigilance Manager
PGA Farma, Brazil
Josue Bautista, PharmD
GCP/PV Auditor
Novartis, Mexico
This session will explore the future of pharmacovigilance (PV) through the evaluation of emerging solutions that are available to support the productivity and quality for PV professionals covering challenges in an increasingly evolving digital world. Attendees will leave this session with a broader understanding of the tools and strategies that are available, increasing their market intelligence of resources that are applicable to their everyday work, and be prepared for the future demands of PV and interactions with key stakeholders after the Covid-19 pandemic.
Learning Objective : - Recognize solutions to support productivity and quality for PV activities
- Evaluate strategies that better support the future demands of PV after the Covid-19 pandemic
- Distinguish the solutions, technological advances, and their values to assess data emergent from the digital world
Speaker(s)
Pandemic Vaccines – a Formidable Challenge for Pharmacovigilance
Alexandre Kiazand, DrMed, MD
AstraZeneca, United States
Head, Global Patient Safety - Vaccines & Immune Therapies
Artificial Intelligence and its Applications in Healthcare
Alexandre Chiavegatto Filho, PhD
University of Sao Paulo, Brazil, Brazil
Associate Professor of Machine Learning in Healthcare
Moderna’s Pharmacovigilance Digital Transformation and Automation Innovation
Juan Camilo Gonzalez, MSc
Moderna, United States
Head of Global Pharmacovigilance Operations
Have an account?